Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,636,637 papers from all fields of science
Search
Sign In
Create Free Account
cancer immunotherapy
Known as:
immunotherapy for cancer
, immunotherapy cancer
, cancer immunotherapies
Expand
Use of techniques, biologically active substances, and procedures to enhance or restore the ability of the host immune system to fight cancer. Also…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
Adoptive Immunotherapy
Immunotherapy
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
STING-mediated DNA sensing in cancer immunotherapy
Xiaoping Zhou
,
Zhengfan Jiang
Science China Life Sciences
2017
Corpus ID: 21954727
While STING (STimulator of INterferon Genes) has been shown to be essential for cytosolic DNA-triggered innate immune activation…
Expand
Review
2017
Review
2017
Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy.
Chao Wang
,
Di Wen
,
Zhen Gu
Bioconjugate chemistry
2017
Corpus ID: 4017723
Cancer immunotherapy has received considerable attention because of a variety of exciting clinical outcomes in recent years. At…
Expand
2015
2015
CANCER IMMUNOTHERAPY. Baby's leukemia recedes after novel cell therapy.
J. Couzin-Frankel
Science
2015
Corpus ID: 12597787
A London baby with end-stage leukemia has received a remarkable new cancer treatment: off-the shelf T cells with several gene…
Expand
Review
2014
Review
2014
Future of cancer vaccines.
H. Winter
,
B. Fox
,
D. Rüttinger
Methods in molecular biology
2014
Corpus ID: 45992283
Extensive research in the area of active-specific immunotherapy has led to the approval of the first therapeutic cancer vaccine…
Expand
Review
2013
Review
2013
The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy.
Wei Li
,
Li Zhang
,
+10 authors
Ya-jun Guo
Mini-Reviews in Medical Chemistry
2013
Corpus ID: 27568936
Cancer is the second leading cause of death around the world. Cancer may be induced by viral infection (EBV,HBV and HPV…
Expand
2006
2006
Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-NaI« ve Prostate Cancer
J. Simons
,
M. Carducci
,
+9 authors
A. Nelson
2006
Corpus ID: 45403106
Purpose: To determine the toxicity, immunologic, and clinical activity of immunotherapy with irradiated,allogeneic…
Expand
Highly Cited
1998
Highly Cited
1998
Genetic immunization against neu /erbB2 transgenic breast cancer
A. Amici
,
F. Venanzi
,
A. Concetti
Cancer Immunology and Immunotherapy
1998
Corpus ID: 25578921
Abstract erbB2/neu, an overexpressed oncogene product, has been proposed as a human cancer vaccine target. In the present study…
Expand
Review
1993
Review
1993
Active Specific Immunotherapy – A New Modality of Cancer Treatment Involving the Patient’s Own Immune System
V. Schirrmacher
1993
Corpus ID: 71335721
This review deals with active specific immunotherapy (ASI) – a type of cancer immunotherapy which involves the use of cancer…
Expand
1977
1977
Heat-killed Pseudomonas aeruginosa as a systemic adjuvant in cancer immunotherapy.
G. Mathé
,
I. Florentin
,
M. Bruley‐Rosset
,
M. Hayat
,
C. Bourut
Biomedicine / [publiee pour l'A.A.I.C.I.G.]
1977
Corpus ID: 34243240
The effect of heat-killed Pseudomonas aeruginosa (10 serotypes) on antibody formation, macrophage activation and leukemia growth…
Expand
1975
1975
The Problem of Cancer Immunotherapy in Perspective
O. Plescia
,
A. Smith
,
K. Grinwich
,
C. Feit
1975
Corpus ID: 82134939
The basic premises underlying cancer immunotherapy are (a) that cancer cells possess cancer-specific transplantation-like…
Expand